APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Disorders Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dermatological Disorders Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173983500322 December 2025191 pages

Choose your research edition.

Industry ResearchDermatological Disorders Medications Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Disorders Medications Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Dermatological Disorders Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Disorders Medications Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Disorders Medications Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dermatological Disorders Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dermatological Disorders Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dermatological Disorders Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dermatological Disorders Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dermatological Disorders Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dermatological Disorders Medications include Novartis, Mylan Pharmaceuticals, Roche, Pfizer, GlaxoSmithKline, Sinclair Pharma, PharmaDerm, Galderma and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dermatological Disorders Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dermatological Disorders Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dermatological Disorders Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dermatological Disorders Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Dermatological Disorders Medications Segment by Company

Novartis

Mylan Pharmaceuticals

Roche

Pfizer

GlaxoSmithKline

Sinclair Pharma

PharmaDerm

Galderma

Bristol-Myers Squibb

Bausch Health

Barrier Therapeutics

Almirall

Dermatological Disorders Medications Segment by Type

Prescription Drugs

Over-The-Counter Drugs

Dermatological Disorders Medications Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Dermatological Disorders Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Disorders Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Disorders Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Disorders Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dermatological Disorders Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dermatological Disorders Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dermatological Disorders Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dermatological Disorders Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dermatological Disorders Medications Industry Trends Table 2. Dermatological Disorders Medications Industry Drivers Table 3. Dermatological Disorders Medications Industry Opportunities and Challenges Table 4. Dermatological Disorders Medications Industry Restraints Table 5. Global Dermatological Disorders Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dermatological Disorders Medications Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dermatological Disorders Medications Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Dermatological Disorders Medications Sales Market Share by Manufacturers Table 9. Global Dermatological Disorders Medications Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Dermatological Disorders Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dermatological Disorders Medications Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dermatological Disorders Medications Manufacturers, Product Type & Application Table 13. Global Dermatological Disorders Medications Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dermatological Disorders Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Prescription Drugs Table 17. Major Manufacturers of Over-The-Counter Drugs Table 18. Global Dermatological Disorders Medications Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Dermatological Disorders Medications Sales by Type (2021-2026) & (k units) Table 20. Global Dermatological Disorders Medications Sales by Type (2027-2032) & (k units) Table 21. Global Dermatological Disorders Medications Sales Market Share by Type (2021-2026) Table 22. Global Dermatological Disorders Medications Sales Market Share by Type (2027-2032) Table 23. Global Dermatological Disorders Medications Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Dermatological Disorders Medications Revenue by Type (2021-2026) & (k units) Table 25. Global Dermatological Disorders Medications Revenue by Type (2027-2032) & (k units) Table 26. Global Dermatological Disorders Medications Revenue Market Share by Type (2021-2026) Table 27. Global Dermatological Disorders Medications Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Online Pharmacies Table 29. Major Manufacturers of Hospital Pharmacies Table 30. Major Manufacturers of Retail Pharmacies Table 31. Global Dermatological Disorders Medications Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Dermatological Disorders Medications Sales by Application (2021-2026) & (k units) Table 33. Global Dermatological Disorders Medications Sales by Application (2027-2032) & (k units) Table 34. Global Dermatological Disorders Medications Sales Market Share by Application (2021-2026) Table 35. Global Dermatological Disorders Medications Sales Market Share by Application (2027-2032) Table 36. Global Dermatological Disorders Medications Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Dermatological Disorders Medications Revenue by Application (2021-2026) & (k units) Table 38. Global Dermatological Disorders Medications Revenue by Application (2027-2032) & (k units) Table 39. Global Dermatological Disorders Medications Revenue Market Share by Application (2021-2026) Table 40. Global Dermatological Disorders Medications Revenue Market Share by Application (2027-2032) Table 41. Global Dermatological Disorders Medications Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Dermatological Disorders Medications Sales by Region (2021-2026) & (k units) Table 43. Global Dermatological Disorders Medications Sales Market Share by Region (2021-2026) Table 44. Global Dermatological Disorders Medications Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Dermatological Disorders Medications Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Dermatological Disorders Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 48. North America Dermatological Disorders Medications Sales by Country (2027-2032) & (k units) Table 49. Europe Dermatological Disorders Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 51. Europe Dermatological Disorders Medications Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Dermatological Disorders Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Dermatological Disorders Medications Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Dermatological Disorders Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Dermatological Disorders Medications Sales by Country (2027-2032) & (k units) Table 58. Global Dermatological Disorders Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dermatological Disorders Medications Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Dermatological Disorders Medications Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dermatological Disorders Medications Revenue Market Share by Region (2021-2026) Table 62. Global Dermatological Disorders Medications Revenue Market Share by Region (2027-2032) Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Novartis Dermatological Disorders Medications Product Portfolio Table 67. Novartis Recent Development Table 68. Mylan Pharmaceuticals Company Information Table 69. Mylan Pharmaceuticals Business Overview Table 70. Mylan Pharmaceuticals Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Mylan Pharmaceuticals Dermatological Disorders Medications Product Portfolio Table 72. Mylan Pharmaceuticals Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Roche Dermatological Disorders Medications Product Portfolio Table 77. Roche Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pfizer Dermatological Disorders Medications Product Portfolio Table 82. Pfizer Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Dermatological Disorders Medications Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Sinclair Pharma Company Information Table 89. Sinclair Pharma Business Overview Table 90. Sinclair Pharma Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sinclair Pharma Dermatological Disorders Medications Product Portfolio Table 92. Sinclair Pharma Recent Development Table 93. PharmaDerm Company Information Table 94. PharmaDerm Business Overview Table 95. PharmaDerm Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. PharmaDerm Dermatological Disorders Medications Product Portfolio Table 97. PharmaDerm Recent Development Table 98. Galderma Company Information Table 99. Galderma Business Overview Table 100. Galderma Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Galderma Dermatological Disorders Medications Product Portfolio Table 102. Galderma Recent Development Table 103. Bristol-Myers Squibb Company Information Table 104. Bristol-Myers Squibb Business Overview Table 105. Bristol-Myers Squibb Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bristol-Myers Squibb Dermatological Disorders Medications Product Portfolio Table 107. Bristol-Myers Squibb Recent Development Table 108. Bausch Health Company Information Table 109. Bausch Health Business Overview Table 110. Bausch Health Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Bausch Health Dermatological Disorders Medications Product Portfolio Table 112. Bausch Health Recent Development Table 113. Barrier Therapeutics Company Information Table 114. Barrier Therapeutics Business Overview Table 115. Barrier Therapeutics Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Barrier Therapeutics Dermatological Disorders Medications Product Portfolio Table 117. Barrier Therapeutics Recent Development Table 118. Almirall Company Information Table 119. Almirall Business Overview Table 120. Almirall Dermatological Disorders Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Almirall Dermatological Disorders Medications Product Portfolio Table 122. Almirall Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Dermatological Disorders Medications Distributors List Table 126. Dermatological Disorders Medications Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Dermatological Disorders Medications Product Image Figure 2. Global Dermatological Disorders Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatological Disorders Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Dermatological Disorders Medications Sales (2021-2032) & (k units) Figure 5. Global Dermatological Disorders Medications Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dermatological Disorders Medications Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Prescription Drugs Image Figure 9. Over-The-Counter Drugs Image Figure 10. Global Dermatological Disorders Medications Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Dermatological Disorders Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dermatological Disorders Medications Sales Market Share by Type (2021-2032) Figure 13. Global Dermatological Disorders Medications Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Dermatological Disorders Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dermatological Disorders Medications Revenue Market Share by Type (2021-2032) Figure 16. Online Pharmacies Image Figure 17. Hospital Pharmacies Image Figure 18. Retail Pharmacies Image Figure 19. Global Dermatological Disorders Medications Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Dermatological Disorders Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Dermatological Disorders Medications Sales Market Share by Application (2021-2032) Figure 22. Global Dermatological Disorders Medications Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Dermatological Disorders Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dermatological Disorders Medications Revenue Market Share by Application (2021-2032) Figure 25. North America Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Dermatological Disorders Medications Sales Market Share by Country (2021-2032) Figure 27. U.S. Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Dermatological Disorders Medications Sales Market Share by Country (2021-2032) Figure 32. Germany Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Dermatological Disorders Medications Sales Market Share by Country (2021-2032) Figure 39. China Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Dermatological Disorders Medications Sales Market Share by Country (2021-2032) Figure 47. Brazil Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Dermatological Disorders Medications Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Dermatological Disorders Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Dermatological Disorders Medications Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Dermatological Disorders Medications Revenue (2021-2032) & (US$ Million) Figure 58. North America Dermatological Disorders Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dermatological Disorders Medications Revenue (2021-2032) & (US$ Million) Figure 60. Europe Dermatological Disorders Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dermatological Disorders Medications Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Dermatological Disorders Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Dermatological Disorders Medications Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Dermatological Disorders Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dermatological Disorders Medications Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Dermatological Disorders Medications Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drugs
  • Over-The-Counter Drugs
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Novartis
  • Mylan Pharmaceuticals
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Sinclair Pharma
  • PharmaDerm
  • Galderma
  • Bristol-Myers Squibb
  • Bausch Health
  • Barrier Therapeutics
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dermatological Disorders Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dermatological Disorders Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dermatological Disorders Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dermatological Disorders Medications Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dermatological Disorders Medications Market Dynamics
  1. 2.1 Dermatological Disorders Medications Industry Trends
  2. 2.2 Dermatological Disorders Medications Industry Drivers
  3. 2.3 Dermatological Disorders Medications Industry Opportunities and Challenges
  4. 2.4 Dermatological Disorders Medications Industry Restraints
3 Dermatological Disorders Medications Market by Manufacturers
  1. 3.1 Global Dermatological Disorders Medications Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dermatological Disorders Medications Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dermatological Disorders Medications Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dermatological Disorders Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dermatological Disorders Medications Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dermatological Disorders Medications Manufacturers, Product Type & Application
  7. 3.7 Global Dermatological Disorders Medications Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dermatological Disorders Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dermatological Disorders Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dermatological Disorders Medications Tier 1, Tier 2, and Tier 3
4 Dermatological Disorders Medications Market by Type
  1. 4.1 Dermatological Disorders Medications Type Introduction
  2. 4.1.1 Prescription Drugs
  3. 4.1.2 Over-The-Counter Drugs
  4. 4.2 Global Dermatological Disorders Medications Sales by Type
  5. 4.2.1 Global Dermatological Disorders Medications Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dermatological Disorders Medications Sales by Type (2021-2032)
  7. 4.2.3 Global Dermatological Disorders Medications Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dermatological Disorders Medications Revenue by Type
  9. 4.3.1 Global Dermatological Disorders Medications Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dermatological Disorders Medications Revenue by Type (2021-2032)
  11. 4.3.3 Global Dermatological Disorders Medications Revenue Market Share by Type (2021-2032)
5 Dermatological Disorders Medications Market by Application
  1. 5.1 Dermatological Disorders Medications Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Dermatological Disorders Medications Sales by Application
  6. 5.2.1 Global Dermatological Disorders Medications Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dermatological Disorders Medications Sales by Application (2021-2032)
  8. 5.2.3 Global Dermatological Disorders Medications Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dermatological Disorders Medications Revenue by Application
  10. 5.3.1 Global Dermatological Disorders Medications Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dermatological Disorders Medications Revenue by Application (2021-2032)
  12. 5.3.3 Global Dermatological Disorders Medications Revenue Market Share by Application (2021-2032)
6 Global Dermatological Disorders Medications Sales by Region
  1. 6.1 Global Dermatological Disorders Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dermatological Disorders Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Dermatological Disorders Medications Sales by Region (2021-2026)
  4. 6.2.2 Global Dermatological Disorders Medications Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dermatological Disorders Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dermatological Disorders Medications Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dermatological Disorders Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dermatological Disorders Medications Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dermatological Disorders Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dermatological Disorders Medications Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dermatological Disorders Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dermatological Disorders Medications Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dermatological Disorders Medications Revenue by Region
  1. 7.1 Global Dermatological Disorders Medications Revenue by Region
  2. 7.1.1 Global Dermatological Disorders Medications Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dermatological Disorders Medications Revenue by Region (2021-2026)
  4. 7.1.3 Global Dermatological Disorders Medications Revenue by Region (2027-2032)
  5. 7.1.4 Global Dermatological Disorders Medications Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dermatological Disorders Medications Revenue (2021-2032)
  8. 7.2.2 North America Dermatological Disorders Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dermatological Disorders Medications Revenue (2021-2032)
  11. 7.3.2 Europe Dermatological Disorders Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dermatological Disorders Medications Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dermatological Disorders Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dermatological Disorders Medications Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dermatological Disorders Medications Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Dermatological Disorders Medications Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Mylan Pharmaceuticals
  8. 8.2.1 Mylan Pharmaceuticals Company Information
  9. 8.2.2 Mylan Pharmaceuticals Business Overview
  10. 8.2.3 Mylan Pharmaceuticals Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Pharmaceuticals Dermatological Disorders Medications Product Portfolio
  12. 8.2.5 Mylan Pharmaceuticals Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Dermatological Disorders Medications Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Dermatological Disorders Medications Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Dermatological Disorders Medications Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Sinclair Pharma
  32. 8.6.1 Sinclair Pharma Company Information
  33. 8.6.2 Sinclair Pharma Business Overview
  34. 8.6.3 Sinclair Pharma Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinclair Pharma Dermatological Disorders Medications Product Portfolio
  36. 8.6.5 Sinclair Pharma Recent Developments
  37. 8.7 PharmaDerm
  38. 8.7.1 PharmaDerm Company Information
  39. 8.7.2 PharmaDerm Business Overview
  40. 8.7.3 PharmaDerm Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PharmaDerm Dermatological Disorders Medications Product Portfolio
  42. 8.7.5 PharmaDerm Recent Developments
  43. 8.8 Galderma
  44. 8.8.1 Galderma Company Information
  45. 8.8.2 Galderma Business Overview
  46. 8.8.3 Galderma Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Galderma Dermatological Disorders Medications Product Portfolio
  48. 8.8.5 Galderma Recent Developments
  49. 8.9 Bristol-Myers Squibb
  50. 8.9.1 Bristol-Myers Squibb Company Information
  51. 8.9.2 Bristol-Myers Squibb Business Overview
  52. 8.9.3 Bristol-Myers Squibb Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bristol-Myers Squibb Dermatological Disorders Medications Product Portfolio
  54. 8.9.5 Bristol-Myers Squibb Recent Developments
  55. 8.10 Bausch Health
  56. 8.10.1 Bausch Health Company Information
  57. 8.10.2 Bausch Health Business Overview
  58. 8.10.3 Bausch Health Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bausch Health Dermatological Disorders Medications Product Portfolio
  60. 8.10.5 Bausch Health Recent Developments
  61. 8.11 Barrier Therapeutics
  62. 8.11.1 Barrier Therapeutics Company Information
  63. 8.11.2 Barrier Therapeutics Business Overview
  64. 8.11.3 Barrier Therapeutics Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Barrier Therapeutics Dermatological Disorders Medications Product Portfolio
  66. 8.11.5 Barrier Therapeutics Recent Developments
  67. 8.12 Almirall
  68. 8.12.1 Almirall Company Information
  69. 8.12.2 Almirall Business Overview
  70. 8.12.3 Almirall Dermatological Disorders Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Almirall Dermatological Disorders Medications Product Portfolio
  72. 8.12.5 Almirall Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dermatological Disorders Medications Value Chain Analysis
  2. 9.1.1 Dermatological Disorders Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dermatological Disorders Medications Production Mode & Process
  6. 9.2 Dermatological Disorders Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dermatological Disorders Medications Distributors
  9. 9.2.3 Dermatological Disorders Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst